Bal Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bal Pharma Ltd. on BSE

Load latest

Bal Pharma Ltd.

11 Aug 2023

91.34

2.65%

Board Meeting

BAL PHARMA LTD. - 524824 - Board Meeting Outcome for Outcome Of The Board Meeting

BSE India

Board of Directors of the Company has met today and inter alia transacted the following business. 1.Taken on record and approved the Un-audited standalone and consolidated financial results of the Company for the quarter ended 30.06.2023. A copy of the approved financial results together with the limited review report issued by the statutory auditors of the Company with unmodified opinion is enclosed with this intimation. 2. Decided to convene 36th Annual General Meeting of the Company on 25th September 2023 i.e on Monday at 10:30 A.M, through audio visual means. 3. Decided to close the Register of Members and Share transfer books of the Company from 19.09.2023 to 25.09.2023 (both days inclusive) to ascertain the entitlement of Dividend and for the 36th Annual General Meeting of the Company. The meeting commenced at 4.30 p.m. and concluded at 5:40 p.m on Friday, 11th August 2023.

pdf

Bal Pharma Ltd.

01 Aug 2023

91.34

2.65%

Board Meeting

BAL PHARMA LTD. - 524824 - Board Meeting Intimation for Approval Of Un-Audited Financial Results For …

BSE India

BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 ,inter alia, to consider and approve 1.Un-Audited Standalone and Consolidated financial results of the Company for the quarter ended 30.06.2023. 2.To convene the 36th Annual General Meeting of the Company. 3. To decide on the Book closure dates. 4. Other AGM related matters.

pdf

Bal Pharma Ltd.

31 Jul 2023

91.34

2.65%

Company Update

BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We are submitting to the exchange newspaper advertisements of Notice issued to our shareholders on 26.07.2023 regarding transfer of equity shares to the IEPF a/c and published in Financial Express ( English ) and Sanjay Vani ( Kannada) , on 31.07.2023.

pdf

Bal Pharma Ltd.

26 Jul 2023

91.34

2.65%

Company Update

BAL PHARMA LTD. - 524824 - Notice To The Shareholders Reg Transfer Of Shares To IEPF …

BSE India

We have circulated the enclosed Notice to all our shareholders whose shares are liable to be transferred to IEPF a/c, for the financial year 2023.24. List of shareholders whose shares are eligible for transfer to IEPF a/c as they have not encased their dividend for the last seven consecutive years , is also uploaded on our website.

pdf

Bal Pharma Ltd.

24 Jul 2023

91.34

2.65%

Company Update

BAL PHARMA LTD. - 524824 - Initial Disclosure -Large Corporate-Revised

BSE India

Pursuant to SEBI Circular No.SEBI/HO/DDHS/P/CIR/2021/613 dated 10th August 2021, we hereby confirm that Bal Pharma Limited is not a large corporate for the financial year 2023-2024.

pdf

Bal Pharma Ltd.

21 Jul 2023

91.34

2.65%

Corp. Note

BAL PHARMA LTD. - 524824 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

We are submitting to the exchange intimation received from our R&T agents regarding loss of share certificate by one of our shareholder.

pdf

Bal Pharma Ltd.

21 Jul 2023

91.34

2.65%

Company Update

BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We are submitting to the exchange, news paper advertisements of the Notice of the Postal ballot issued to our shareholders on 20.07.2023 and published in Financial Express ( English) and Sanjayvani ( Kannada ) newspapers on 21.07.2023

pdf

Bal Pharma Ltd.

20 Jul 2023

91.34

2.65%

AGM

BAL PHARMA LTD. - 524824 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

BSE India

We are submitting to the exchange copy of the Postal Ballot Notice that is being circulated among the shareholders of the Company seeking their approval for Appointment of Ms.Nicola Neeladri ( DIN # 01997936 ) as Independent Director of the Company by a special resolution.

pdf

Bal Pharma Ltd.

17 Jul 2023

91.34

2.65%

Company Update

BAL PHARMA LTD. - 524824 - Appointment of Company Secretary and Compliance Officer

BSE India

As per the provisions of Section 203 of the Companies Act,2013, the Board of Directors of the Company at their meeting held on 17.07.2023 has appointed Mr.Abdul Basith ( Membership # A70640) as Company Secretary and Compliance Officer of the Company.

pdf

Bal Pharma Ltd.

03 Jul 2023

91.34

2.65%

Company Update

BAL PHARMA LTD. - 524824 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Based on the certificate received from our R&T agents i.e TSR Darashaw Pvt Ltd, we would like to confirm that the details of securities dematerialized /rematerialized during the quarter ended 30.06.2023 have been furnished to all the stock exchanges where the equity shares of the Company are listed , within the prescribed time limit. The share certificates received for dematerialization , if any have been mutilated and cancelled after due verification and the name of the depository has been substituted in the records as registered owner , within 15 days of the receipt of the certificate of security.

pdf

Is Bal Pharma Ltd. worth buying?

53 Votes:

Buy 75.47%

Sell 13.21%

Hold 11.32%